Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DROP-ROP: Propranolol Eye Drops in Retinopathy of Prematurity
2013-002062-39Phase 2Terminated
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of propranolol in retinopathy of prematurity (ROP), sponsored by Meyer Children's Hospital IRCCS. Started Sep 2013; status: terminated.
02
Drugs
propranolol
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on 2013-002062-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002062-39.